[{"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-001", "question": "A 14-year-old boy with a history of recurrent epistaxis presents with progressive dyspnea and hemoptysis. Physical examination reveals telangiectasias on the lips and oral mucosa. Pulmonary angiography shows multiple arteriovenous malformations. Genetic testing confirms a mutation in the ENG gene. What is the most appropriate long-term management strategy to prevent recurrent pulmonary complications?", "options": ["Prophylactic coil embolization of all visible AVMs", "Lifelong anticoagulation with warfarin", "Serial transcatheter embolotherapy guided by symptom recurrence", "Surgical lobectomy for affected lung segments", "Observation with annual CT angiography"], "answer": "C", "answer_index": 2, "explanation": "In hereditary hemorrhagic telangiectasia (HHT) due to ENG mutation, pulmonary AVMs are managed with transcatheter embolotherapy, repeated as needed based on symptoms or imaging, as complete eradication is often not feasible and new AVMs can develop. Prophylactic embolization of all AVMs risks unnecessary procedures and complications, while anticoagulation increases bleeding risk without addressing AVMs. Surgical options are reserved for cases unresponsive to embolization.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 14-year-old boy, recurrent epistaxis, mucocutaneous telangiectasias, pulmonary AVMs on angiography, ENG mutation → classic hereditary hemorrhagic telangiectasia (HHT). Question asks for long-term strategy to prevent recurrent pulmonary complications.\\nMost appropriate management in HHT with pulmonary AVMs is catheter-based embolization of clinically significant AVMs, with repeat (serial) embolization over time as new lesions or symptoms arise; complete lifelong cure is uncommon. Thus, option C (serial transcatheter embolotherapy guided by symptom recurrence) fits best among given choices.\\nWhy alternatives are worse: A (prophylactic coil embolization of all visible AVMs) overstates practice—tiny/low-risk lesions are often observed; focus is on those meeting size/feeding-artery criteria, not literally “all visible.” B (lifelong anticoagulation) is contraindicated given bleeding tendency and does not treat AVMs. D (lobectomy) is reserved for rare cases not amenable to embolization. E (observation alone) omits needed embolization in a symptomatic patient.\\nMain medical accuracy: Overall accurate and consistent with current HHT management, though option C’s wording (“guided by symptom recurrence”) could also mention imaging surveillance.\\nMinimal fix: Rephrase C as “Serial transcatheter embolization of clinically significant AVMs with periodic imaging surveillance.”\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 14-year-old boy, recurrent epistaxis, mucocutaneous telangiectasias, pulmonary AVMs on angiography, ENG mutation → classic hereditary hemorrhagic telangiectasia (HHT). Question asks for long-term strategy to prevent recurrent pulmonary complications.\nMost appropriate management in HHT with pulmonary AVMs is catheter-based embolization of clinically significant AVMs, with repeat (serial) embolization over time as new lesions or symptoms arise; complete lifelong cure is uncommon. Thus, option C (serial transcatheter embolotherapy guided by symptom recurrence) fits best among given choices.\nWhy alternatives are worse: A (prophylactic coil embolization of all visible AVMs) overstates practice—tiny/low-risk lesions are often observed; focus is on those meeting size/feeding-artery criteria, not literally “all visible.” B (lifelong anticoagulation) is contraindicated given bleeding tendency and does not treat AVMs. D (lobectomy) is reserved for rare cases not amenable to embolization. E (observation alone) omits needed embolization in a symptomatic patient.\nMain medical accuracy: Overall accurate and consistent with current HHT management, though option C’s wording (“guided by symptom recurrence”) could also mention imaging surveillance.\nMinimal fix: Rephrase C as “Serial transcatheter embolization of clinically significant AVMs with periodic imaging surveillance.”", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-002", "question": "A 6-month-old infant with known tetralogy of Fallot develops sudden cyanosis and agitation during a routine clinic visit. The child is tachypneic with oxygen saturation of 65%. Echocardiography shows severe right ventricular outflow tract obstruction. After initial stabilization with knee-to-chest positioning and morphine, what is the next best pharmacologic intervention to abort the hypercyanotic spell?", "options": ["Intravenous propranolol", "Subcutaneous epinephrine", "Intravenous phenylephrine", "Oral sildenafil", "Intravenous esmolol"], "answer": "C", "answer_index": 2, "explanation": "Phenylephrine increases systemic vascular resistance, reducing right-to-left shunting in tetralogy of Fallot during a hypercyanotic spell. Propranolol or esmolol may be used but are not first-line for acute spells; epinephrine could worsen infundibular spasm. Sildenafil is not indicated acutely for this scenario.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 6‑month‑old with known tetralogy of Fallot, sudden cyanosis and agitation, severe RVOT obstruction on echo, acute \\\"tet spell\\\" despite initial knee‑to‑chest and morphine, asking for next best pharmacologic intervention to abort the hypercyanotic spell. In TOF spells, the principal goal is to increase systemic vascular resistance and reduce right‑to‑left shunting; IV phenylephrine (pure alpha‑agonist) is classically used acutely for this purpose.\\n\\nOption appraisal:\\n- C (phenylephrine): Best choice; directly raises SVR, improves pulmonary blood flow, and is textbook acute therapy for a tet spell.\\n- A (IV propranolol): Beta‑blockers (often propranolol) can be used, but typically as adjuncts or for prevention/less acute management, not the immediate preferred vasoconstrictor after position and sedation.\\n- E (IV esmolol): Similar concept to propranolol but less standard in pediatric congenital heart disease management; not first‑line.\\n- B (SC epinephrine): Beta effects may worsen infundibular spasm; not recommended.\\n- D (oral sildenafil): Chronic pulmonary vasodilator; inappropriate acutely and pathophysiologically counterproductive.\\n\\nMain medical accuracy issues: None significant; explanation aligns with standard teaching.\\nMinimal fix: Specify “after positioning, oxygen, volume as needed, and morphine” to match common protocols, but not required for uniqueness.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 6‑month‑old with known tetralogy of Fallot, sudden cyanosis and agitation, severe RVOT obstruction on echo, acute \"tet spell\" despite initial knee‑to‑chest and morphine, asking for next best pharmacologic intervention to abort the hypercyanotic spell. In TOF spells, the principal goal is to increase systemic vascular resistance and reduce right‑to‑left shunting; IV phenylephrine (pure alpha‑agonist) is classically used acutely for this purpose.\n\nOption appraisal:\n- C (phenylephrine): Best choice; directly raises SVR, improves pulmonary blood flow, and is textbook acute therapy for a tet spell.\n- A (IV propranolol): Beta‑blockers (often propranolol) can be used, but typically as adjuncts or for prevention/less acute management, not the immediate preferred vasoconstrictor after position and sedation.\n- E (IV esmolol): Similar concept to propranolol but less standard in pediatric congenital heart disease management; not first‑line.\n- B (SC epinephrine): Beta effects may worsen infundibular spasm; not recommended.\n- D (oral sildenafil): Chronic pulmonary vasodilator; inappropriate acutely and pathophysiologically counterproductive.\n\nMain medical accuracy issues: None significant; explanation aligns with standard teaching.\nMinimal fix: Specify “after positioning, oxygen, volume as needed, and morphine” to match common protocols, but not required for uniqueness.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-003", "question": "A 9-year-old girl with neurofibromatosis type 1 presents with hypertension and headaches. MRI reveals a pheochromocytoma and bilateral renal artery stenosis. Genetic analysis confirms NF1 mutation. What is the most appropriate initial management for her hypertension prior to surgical intervention?", "options": ["Alpha-blockade with phenoxybenzamine followed by beta-blockade", "Angiotensin-converting enzyme inhibitor monotherapy", "Percutaneous renal artery angioplasty", "Calcium channel blocker initiation", "Surgical resection of pheochromocytoma without preoperative preparation"], "answer": "A", "answer_index": 0, "explanation": "In pheochromocytoma associated with NF1, preoperative alpha-blockade followed by beta-blockade is essential to prevent hypertensive crisis during surgery. ACE inhibitors may exacerbate renal stenosis issues, and angioplasty or surgery without preparation risks catecholamine surge. Calcium channel blockers are not sufficient alone.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 9-year-old with NF1, hypertension and headaches, MRI-confirmed pheochromocytoma plus bilateral renal artery stenosis; question explicitly asks for “initial management for her hypertension prior to surgical intervention.” In a child with pheochromocytoma scheduled for surgery, standard of care is preoperative alpha-adrenergic blockade, typically with phenoxybenzamine, followed by beta-blockade if needed for tachycardia.\\n\\nChoice A correctly describes this sequence and directly addresses the perioperative blood pressure management. B (ACE inhibitor monotherapy) is inappropriate and relatively contraindicated in bilateral renal artery stenosis and fails to address catecholamine-driven crisis risk. C (angioplasty) is a later structural intervention for renal artery stenosis, not initial perioperative BP management for pheochromocytoma. D (CCB alone) can be used as adjunct/alternative in some settings but is not the standard “most appropriate” first-line regimen before adrenalectomy when alpha-blockade is available. E (surgery without preparation) is clearly unsafe.\\n\\nMain medical accuracy issue: minor—CCBs can be effective but are generally second-line to alpha blockade; explanation slightly overstates insufficiency. \\n\\nMinimal fix: Clarify in explanation that CCBs are possible alternatives but alpha-blockade is preferred standard in this context.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 9-year-old with NF1, hypertension and headaches, MRI-confirmed pheochromocytoma plus bilateral renal artery stenosis; question explicitly asks for “initial management for her hypertension prior to surgical intervention.” In a child with pheochromocytoma scheduled for surgery, standard of care is preoperative alpha-adrenergic blockade, typically with phenoxybenzamine, followed by beta-blockade if needed for tachycardia.\n\nChoice A correctly describes this sequence and directly addresses the perioperative blood pressure management. B (ACE inhibitor monotherapy) is inappropriate and relatively contraindicated in bilateral renal artery stenosis and fails to address catecholamine-driven crisis risk. C (angioplasty) is a later structural intervention for renal artery stenosis, not initial perioperative BP management for pheochromocytoma. D (CCB alone) can be used as adjunct/alternative in some settings but is not the standard “most appropriate” first-line regimen before adrenalectomy when alpha-blockade is available. E (surgery without preparation) is clearly unsafe.\n\nMain medical accuracy issue: minor—CCBs can be effective but are generally second-line to alpha blockade; explanation slightly overstates insufficiency. \n\nMinimal fix: Clarify in explanation that CCBs are possible alternatives but alpha-blockade is preferred standard in this context.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-004", "question": "A neonate with congenital diaphragmatic hernia undergoes surgical repair at 48 hours of life. Postoperatively, the infant develops persistent pulmonary hypertension with right-to-left shunting on echocardiography. Despite maximal ventilatory support and inhaled nitric oxide, oxygenation remains poor. What is the most appropriate next step in management?", "options": ["Initiation of extracorporeal membrane oxygenation", "Administration of intravenous milrinone", "High-frequency oscillatory ventilation trial", "Surgical revision of hernia repair", "Prostaglandin E1 infusion"], "answer": "A", "answer_index": 0, "explanation": "ECMO is indicated for refractory pulmonary hypertension in congenital diaphragmatic hernia when conventional therapies fail. Milrinone may help but is not superior to ECMO in severe cases; HFOV is already part of maximal support. Surgical revision or PGE1 is not appropriate without evidence of ductal dependency.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: neonate with congenital diaphragmatic hernia, postoperative persistent pulmonary hypertension, right-to-left shunting on echo, poor oxygenation despite *maximal ventilatory support* and inhaled nitric oxide. These features define severe, refractory PPHN in CDH after failure of conventional (including HFOV) and selective pulmonary vasodilator therapy, which is a classic indication for ECMO in appropriate centers.\\n\\nOption A (ECMO) fits best as escalation for refractory hypoxemic respiratory failure with PPHN. Option B (milrinone) can be an adjunctive pulmonary vasodilator/inotrope but is not standardly used *after* failure of iNO and maximal support as the next definitive step in a critically unstable neonate, and evidence is limited; ECMO is more established. Option C (HFOV) is made less likely by the stem’s phrase “maximal ventilatory support,” reasonably implying advanced modes have already been used. Option D (surgical revision) is not indicated without mechanical complication or recurrent herniation. Option E (PGE1) is for maintaining ductal patency in ductal-dependent congenital heart disease, not for primary PPHN/CDH without evidence of ductal-dependent lesion.\\n\\nMinimal fix: Explicitly state that the infant is already on high-frequency ventilation as part of “maximal ventilatory support” to remove any ambiguity about option C.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: neonate with congenital diaphragmatic hernia, postoperative persistent pulmonary hypertension, right-to-left shunting on echo, poor oxygenation despite *maximal ventilatory support* and inhaled nitric oxide. These features define severe, refractory PPHN in CDH after failure of conventional (including HFOV) and selective pulmonary vasodilator therapy, which is a classic indication for ECMO in appropriate centers.\n\nOption A (ECMO) fits best as escalation for refractory hypoxemic respiratory failure with PPHN. Option B (milrinone) can be an adjunctive pulmonary vasodilator/inotrope but is not standardly used *after* failure of iNO and maximal support as the next definitive step in a critically unstable neonate, and evidence is limited; ECMO is more established. Option C (HFOV) is made less likely by the stem’s phrase “maximal ventilatory support,” reasonably implying advanced modes have already been used. Option D (surgical revision) is not indicated without mechanical complication or recurrent herniation. Option E (PGE1) is for maintaining ductal patency in ductal-dependent congenital heart disease, not for primary PPHN/CDH without evidence of ductal-dependent lesion.\n\nMinimal fix: Explicitly state that the infant is already on high-frequency ventilation as part of “maximal ventilatory support” to remove any ambiguity about option C.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-005", "question": "A 32-year-old woman at 28 weeks gestation with a history of antiphospholipid syndrome presents with severe preeclampsia. Laboratory evaluation shows thrombocytopenia, elevated liver enzymes, and hemolysis. Fetal monitoring indicates non-reassuring heart rate patterns. What is the most appropriate immediate management?", "options": ["Expectant management with close monitoring", "Immediate delivery via cesarean section", "Administration of intravenous magnesium sulfate alone", "Plasma exchange therapy", "High-dose corticosteroid initiation"], "answer": "B", "answer_index": 1, "explanation": "In HELLP syndrome superimposed on preeclampsia in antiphospholipid syndrome, immediate delivery is indicated at 28 weeks due to maternal and fetal risks. Expectant management is not suitable beyond 34 weeks or with severe features; magnesium prevents seizures but does not address the need for delivery. Plasma exchange and steroids are not first-line.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 28 weeks gestation, history of antiphospholipid syndrome, severe preeclampsia, lab evidence of HELLP (hemolysis, elevated liver enzymes, low platelets), and non-reassuring fetal heart rate patterns. These indicate a high-risk maternal–fetal situation where continuation of pregnancy is unsafe. Standard obstetric management for severe preeclampsia with HELLP and nonreassuring fetal status at ≥24 weeks is prompt delivery, regardless of gestational age. Given the unstable fetal status, cesarean delivery is the most appropriate immediate route.\\nOption analysis: A (expectant management) is contraindicated in the presence of HELLP and nonreassuring tracings. C (magnesium sulfate) is correctly used for seizure prophylaxis but is adjunctive, not definitive, and cannot replace delivery. D (plasma exchange) is not first-line for HELLP in this context. E (high-dose corticosteroids) may be used for fetal lung maturity or maternal benefit but again does not address the need for urgent delivery.\\nMain medical/logical issues: Minor wording: “beyond 34 weeks” in the explanation is slightly off; here, the severity itself mandates delivery. Minimal fix: Clarify in the explanation that severe features and nonreassuring fetal status mandate delivery at any viable gestation.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 28 weeks gestation, history of antiphospholipid syndrome, severe preeclampsia, lab evidence of HELLP (hemolysis, elevated liver enzymes, low platelets), and non-reassuring fetal heart rate patterns. These indicate a high-risk maternal–fetal situation where continuation of pregnancy is unsafe. Standard obstetric management for severe preeclampsia with HELLP and nonreassuring fetal status at ≥24 weeks is prompt delivery, regardless of gestational age. Given the unstable fetal status, cesarean delivery is the most appropriate immediate route.\nOption analysis: A (expectant management) is contraindicated in the presence of HELLP and nonreassuring tracings. C (magnesium sulfate) is correctly used for seizure prophylaxis but is adjunctive, not definitive, and cannot replace delivery. D (plasma exchange) is not first-line for HELLP in this context. E (high-dose corticosteroids) may be used for fetal lung maturity or maternal benefit but again does not address the need for urgent delivery.\nMain medical/logical issues: Minor wording: “beyond 34 weeks” in the explanation is slightly off; here, the severity itself mandates delivery. Minimal fix: Clarify in the explanation that severe features and nonreassuring fetal status mandate delivery at any viable gestation.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-006", "question": "A 28-year-old primigravida at 36 weeks gestation presents with vaginal bleeding and abdominal pain. Ultrasound reveals placental abruption with fetal bradycardia. Coagulation studies show prolonged PT and PTT, low fibrinogen, and elevated D-dimer. What is the most critical initial intervention?", "options": ["Immediate cesarean delivery under general anesthesia", "Transfusion of fresh frozen plasma and cryoprecipitate", "Administration of recombinant factor VIIa", "Expectant management with tocolysis", "Intrauterine balloon tamponade"], "answer": "B", "answer_index": 1, "explanation": "Abruption with disseminated intravascular coagulation requires urgent correction of coagulopathy with FFP and cryoprecipitate to enable safe delivery. Immediate cesarean without addressing DIC risks massive hemorrhage; factor VIIa is reserved for refractory cases. Expectant management or tamponade is inappropriate with fetal compromise.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – best answer is A, not B.\\nKey stem clues: Term patient (36 weeks) with placental abruption, painful bleeding, and fetal bradycardia indicates acute fetal distress and an obstetric emergency requiring immediate delivery. Coagulation profile (prolonged PT/PTT, low fibrinogen, elevated D-dimer) shows DIC secondary to abruption.\\nLogical issues: In a crashing abruption with nonreassuring fetal status, the most critical initial intervention is rapid delivery (typically emergent cesarean) to save the fetus and stop the source of hemorrhage; blood products are initiated concurrently but are supportive and cannot precede life-saving delivery. Choice B describes important management but is not the “most critical initial intervention” given fetal bradycardia and viable gestational age. Thus, the stem supports a unique best answer (A), but the key selects B.\\nMedical accuracy: The description of DIC labs is correct, and use of FFP/cryoprecipitate is appropriate, but the prioritization over emergent delivery conflicts with standard obstetric management of abruption with fetal distress.\\nMinimal fix: Change the keyed answer to A, or modify the stem to indicate hemodynamic collapse without operative capability where immediate correction of coagulopathy is indeed the first step.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – best answer is A, not B.\nKey stem clues: Term patient (36 weeks) with placental abruption, painful bleeding, and fetal bradycardia indicates acute fetal distress and an obstetric emergency requiring immediate delivery. Coagulation profile (prolonged PT/PTT, low fibrinogen, elevated D-dimer) shows DIC secondary to abruption.\nLogical issues: In a crashing abruption with nonreassuring fetal status, the most critical initial intervention is rapid delivery (typically emergent cesarean) to save the fetus and stop the source of hemorrhage; blood products are initiated concurrently but are supportive and cannot precede life-saving delivery. Choice B describes important management but is not the “most critical initial intervention” given fetal bradycardia and viable gestational age. Thus, the stem supports a unique best answer (A), but the key selects B.\nMedical accuracy: The description of DIC labs is correct, and use of FFP/cryoprecipitate is appropriate, but the prioritization over emergent delivery conflicts with standard obstetric management of abruption with fetal distress.\nMinimal fix: Change the keyed answer to A, or modify the stem to indicate hemodynamic collapse without operative capability where immediate correction of coagulopathy is indeed the first step.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-007", "question": "A 40-year-old woman with a history of endometriosis undergoes laparoscopic hysterectomy. Intraoperatively, she develops sudden hypotension, tachycardia, and increased end-tidal CO2. Arterial blood gas shows respiratory acidosis. What is the most likely diagnosis, and what is the immediate management?", "options": ["Venous air embolism; hyperventilation and left lateral positioning", "CO2 embolism; increase insufflation pressure", "Anaphylaxis to latex; epinephrine administration", "Hemorrhagic shock; fluid resuscitation", "Malignant hyperthermia; dantrolene infusion"], "answer": "A", "answer_index": 0, "explanation": "CO2 embolism during laparoscopy presents with hypotension, tachycardia, and elevated ETCO2; management includes hyperventilation, left lateral positioning, and aspiration if possible. Increasing pressure worsens embolism; anaphylaxis lacks ETCO2 rise. Hemorrhage or hyperthermia have different presentations.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed — option A’s diagnosis is wrong though its management matches the explanation.\\nKey stem clues: Laparoscopic procedure with pneumoperitoneum, acute hypotension and tachycardia, *increased* end-tidal CO₂ and respiratory acidosis. This pattern is classic for CO₂ absorption/embolism rather than air embolism. Venous air embolism characteristically causes a sudden *drop* in ETCO₂ from increased dead space. Anaphylaxis would typically cause hypotension with bronchospasm and often *decreased* ETCO₂; hemorrhagic shock would not raise ETCO₂; malignant hyperthermia features hypercarbia with muscle rigidity and rapidly rising temperature, not described here.\\nMain logical issue: The provided key and option A name the wrong embolic agent (air instead of CO₂) but the explanatory text correctly describes CO₂ embolism and its management, creating a miskey: the best-supported diagnosis is CO₂ embolism with hyperventilation and left lateral positioning, yet no option states that combination correctly.\\nMain medical accuracy issue: Mislabeling the embolism type; management for air vs CO₂ embolism overlaps, but physiologic pattern and etiology here are CO₂-related.\\nMinimal fix: Change option A’s stem to “CO₂ embolism; hyperventilation and left lateral positioning,” and change option B to a different, clearly incorrect intervention.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed — option A’s diagnosis is wrong though its management matches the explanation.\nKey stem clues: Laparoscopic procedure with pneumoperitoneum, acute hypotension and tachycardia, *increased* end-tidal CO₂ and respiratory acidosis. This pattern is classic for CO₂ absorption/embolism rather than air embolism. Venous air embolism characteristically causes a sudden *drop* in ETCO₂ from increased dead space. Anaphylaxis would typically cause hypotension with bronchospasm and often *decreased* ETCO₂; hemorrhagic shock would not raise ETCO₂; malignant hyperthermia features hypercarbia with muscle rigidity and rapidly rising temperature, not described here.\nMain logical issue: The provided key and option A name the wrong embolic agent (air instead of CO₂) but the explanatory text correctly describes CO₂ embolism and its management, creating a miskey: the best-supported diagnosis is CO₂ embolism with hyperventilation and left lateral positioning, yet no option states that combination correctly.\nMain medical accuracy issue: Mislabeling the embolism type; management for air vs CO₂ embolism overlaps, but physiologic pattern and etiology here are CO₂-related.\nMinimal fix: Change option A’s stem to “CO₂ embolism; hyperventilation and left lateral positioning,” and change option B to a different, clearly incorrect intervention.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-008", "question": "A 55-year-old man undergoing coronary artery bypass grafting develops refractory hypotension post-cardiopulmonary bypass. Echocardiography shows right ventricular dilation and septal shift. Pulmonary artery catheter reveals elevated pulmonary artery pressures. What is the most appropriate pharmacologic intervention?", "options": ["Inhaled nitric oxide", "Intravenous dobutamine", "Milrinone infusion", "Norepinephrine bolus", "Vasopressin drip"], "answer": "A", "answer_index": 0, "explanation": "Prototypical right ventricular failure post-CABG with pulmonary hypertension responds best to inhaled nitric oxide as a selective pulmonary vasodilator. Dobutamine and milrinone may help inotropy but not selectively reduce PVR; norepinephrine and vasopressin are systemic vasopressors without pulmonary specificity.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: Post–cardiopulmonary bypass, refractory hypotension, echocardiographic evidence of acute right ventricular failure (RV dilation, septal shift), elevated pulmonary artery pressures. Question asks for “most appropriate pharmacologic intervention.” \\nIn acute RV failure with pulmonary hypertension, inhaled nitric oxide is a selective pulmonary vasodilator that can rapidly reduce RV afterload without systemic hypotension; this supports A. However, the patient is already hypotensive (“refractory hypotension”), so agents that further reduce systemic vascular resistance are risky. Milrinone (C) is also a pulmonary vasodilator and inodilator but tends to worsen hypotension and is less appropriate here. Dobutamine (B) improves RV contractility and can support cardiac output in hypotension, and is commonly used first-line for acute RV failure; guidelines and practice patterns can support B as an equally or more appropriate initial pharmacologic choice. The stem does not specify existing inotropic/vasopressor support, oxygenation, or ventilator settings, making relative priority between selective pulmonary vasodilation versus inotropy underspecified. No option is clearly dominant; both A and B are defendable. Medical content is otherwise accurate. \\nMinimal fix: Add a clause indicating the patient remains hypotensive despite adequate inotropic and vasopressor support, focusing the question on targeted pulmonary vasodilation, or reword to ask specifically for a selective pulmonary vasodilator.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: Post–cardiopulmonary bypass, refractory hypotension, echocardiographic evidence of acute right ventricular failure (RV dilation, septal shift), elevated pulmonary artery pressures. Question asks for “most appropriate pharmacologic intervention.” \nIn acute RV failure with pulmonary hypertension, inhaled nitric oxide is a selective pulmonary vasodilator that can rapidly reduce RV afterload without systemic hypotension; this supports A. However, the patient is already hypotensive (“refractory hypotension”), so agents that further reduce systemic vascular resistance are risky. Milrinone (C) is also a pulmonary vasodilator and inodilator but tends to worsen hypotension and is less appropriate here. Dobutamine (B) improves RV contractility and can support cardiac output in hypotension, and is commonly used first-line for acute RV failure; guidelines and practice patterns can support B as an equally or more appropriate initial pharmacologic choice. The stem does not specify existing inotropic/vasopressor support, oxygenation, or ventilator settings, making relative priority between selective pulmonary vasodilation versus inotropy underspecified. No option is clearly dominant; both A and B are defendable. Medical content is otherwise accurate. \nMinimal fix: Add a clause indicating the patient remains hypotensive despite adequate inotropic and vasopressor support, focusing the question on targeted pulmonary vasodilation, or reword to ask specifically for a selective pulmonary vasodilator.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-009", "question": "A 70-year-old woman with chronic obstructive pulmonary disease is intubated for type II respiratory failure during total hip replacement. Post-extubation, she develops stridor and respiratory distress. Laryngoscopy reveals bilateral vocal cord paralysis. What is the most likely etiology, and what is the definitive management?", "options": ["Arytenoid dislocation from intubation; surgical repositioning", "Recurrent laryngeal nerve injury; tracheostomy", "Hypocalcemia-induced spasm; calcium gluconate", "Anesthetic-induced neuropathy; observation", "Allergic reaction; steroids and antihistamines"], "answer": "A", "answer_index": 0, "explanation": "Arytenoid dislocation is a rare complication of intubation causing vocal cord immobility; management involves endoscopic or surgical repositioning. Nerve injury typically presents unilaterally; hypocalcemia is unlikely without parathyroid involvement. Neuropathy or allergy do not fit the acute bilateral presentation.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible, with miskey tendency)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: Elderly woman, recent endotracheal intubation for surgery, immediate post‑extubation stridor and respiratory distress, laryngoscopy showing *bilateral* vocal cord paralysis. The question asks for most likely etiology and definitive management.\\nProblem: Both arytenoid dislocation and recurrent laryngeal nerve injury are recognized complications of intubation that can present with acute bilateral vocal fold immobility and stridor. The stem provides no specific findings (e.g., cricoarytenoid joint abnormality, EMG, timing, hoarseness pattern) to distinguish joint dislocation from nerve paralysis. The explanation’s claim that recurrent laryngeal nerve injury “typically presents unilaterally” is generally true but not exclusive; bilateral RLN injury after intubation is well-known and life‑threatening, often treated with tracheostomy as definitive airway management. Thus option B is also medically defensible.\\nMedical accuracy: Mechanisms and treatments of A and B are broadly correct, but the assertion that nerve injury is effectively ruled out is oversimplified.\\nMinimal fix: Add a discriminating clue (e.g., “CT and laryngeal EMG show normal nerve function with arytenoid malposition”) or reframe stem to specify dislocation was demonstrated, thereby uniquely supporting option A.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible, with miskey tendency)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: Elderly woman, recent endotracheal intubation for surgery, immediate post‑extubation stridor and respiratory distress, laryngoscopy showing *bilateral* vocal cord paralysis. The question asks for most likely etiology and definitive management.\nProblem: Both arytenoid dislocation and recurrent laryngeal nerve injury are recognized complications of intubation that can present with acute bilateral vocal fold immobility and stridor. The stem provides no specific findings (e.g., cricoarytenoid joint abnormality, EMG, timing, hoarseness pattern) to distinguish joint dislocation from nerve paralysis. The explanation’s claim that recurrent laryngeal nerve injury “typically presents unilaterally” is generally true but not exclusive; bilateral RLN injury after intubation is well-known and life‑threatening, often treated with tracheostomy as definitive airway management. Thus option B is also medically defensible.\nMedical accuracy: Mechanisms and treatments of A and B are broadly correct, but the assertion that nerve injury is effectively ruled out is oversimplified.\nMinimal fix: Add a discriminating clue (e.g., “CT and laryngeal EMG show normal nerve function with arytenoid malposition”) or reframe stem to specify dislocation was demonstrated, thereby uniquely supporting option A.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-010", "question": "A 45-year-old man with treatment-resistant depression and a history of electroconvulsive therapy presents with catatonia, mutism, and waxy flexibility. He has not responded to lorazepam. What is the most appropriate next step in management?", "options": ["Bilateral electroconvulsive therapy", "Intravenous amobarbital challenge", "High-dose olanzapine initiation", "Repetitive transcranial magnetic stimulation", "Ketamine infusion trial"], "answer": "A", "answer_index": 0, "explanation": "ECT is the treatment of choice for catatonia unresponsive to benzodiazepines, with high efficacy in psychiatric emergencies. Amobarbital is outdated and not standard; olanzapine may help but is not first-line for refractory cases. rTMS and ketamine lack strong evidence for acute catatonia.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: treatment‑resistant depression, prior ECT exposure (tolerated/known), current presentation with classic catatonia (mutism, waxy flexibility), and failure to respond to lorazepam. The question asks for the next step in acute management of benzodiazepine‑refractory catatonia.\\n\\nMost likely intended diagnosis/management: Catatonia refractory to first-line benzodiazepine, for which electroconvulsive therapy is the standard next-line treatment in modern practice, especially in psychiatric emergencies.\\n\\nOption analysis:\\n- A (bilateral ECT): Consistent with guidelines as treatment of choice after lorazepam failure in catatonia, even in patients previously treated with ECT for other indications.\\n- B (IV amobarbital challenge): Historically used diagnostically/therapeutically but now largely obsolete and not standard of care.\\n- C (high-dose olanzapine): Antipsychotics may worsen catatonia or precipitate malignant catatonia/NMS; not first-line.\\n- D (rTMS): Not established for acute catatonia; evidence limited.\\n- E (ketamine): Emerging data but not standard or first choice.\\n\\nNo major internal contradictions or need for unstated assumptions; the prior history of ECT does not contraindicate its reuse.\\n\\nMinimal fix: Explicitly state “despite adequate lorazepam trial” to emphasize benzodiazepine failure as prerequisite for ECT step-up.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: treatment‑resistant depression, prior ECT exposure (tolerated/known), current presentation with classic catatonia (mutism, waxy flexibility), and failure to respond to lorazepam. The question asks for the next step in acute management of benzodiazepine‑refractory catatonia.\n\nMost likely intended diagnosis/management: Catatonia refractory to first-line benzodiazepine, for which electroconvulsive therapy is the standard next-line treatment in modern practice, especially in psychiatric emergencies.\n\nOption analysis:\n- A (bilateral ECT): Consistent with guidelines as treatment of choice after lorazepam failure in catatonia, even in patients previously treated with ECT for other indications.\n- B (IV amobarbital challenge): Historically used diagnostically/therapeutically but now largely obsolete and not standard of care.\n- C (high-dose olanzapine): Antipsychotics may worsen catatonia or precipitate malignant catatonia/NMS; not first-line.\n- D (rTMS): Not established for acute catatonia; evidence limited.\n- E (ketamine): Emerging data but not standard or first choice.\n\nNo major internal contradictions or need for unstated assumptions; the prior history of ECT does not contraindicate its reuse.\n\nMinimal fix: Explicitly state “despite adequate lorazepam trial” to emphasize benzodiazepine failure as prerequisite for ECT step-up.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-011", "question": "A 2-year-old boy with hypoplastic left heart syndrome post-Norwood procedure presents with feeding intolerance and metabolic acidosis. Echocardiography shows preserved ventricular function but elevated right atrial pressure. Cardiac catheterization reveals stenosis at the neo-aortic arch. What is the most appropriate intervention?", "options": ["Balloon angioplasty of the arch stenosis", "Surgical arch augmentation", "Fontan completion procedure", "Heart transplantation evaluation", "Medical management with afterload reduction"], "answer": "B", "answer_index": 1, "explanation": "Surgical augmentation is preferred for neo-aortic arch stenosis in HLHS post-Norwood due to better long-term patency than balloon angioplasty, which has high restenosis rates. Fontan is premature; transplantation is for end-stage failure. Medical management does not address the anatomic issue.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 2-year-old with hypoplastic left heart syndrome status post-Norwood; now has feeding intolerance and metabolic acidosis (low-output/systemic hypoperfusion signs), echo with preserved ventricular function but elevated right atrial pressure, and catheterization documenting stenosis at the neo-aortic arch. The clinical problem is symptomatic obstruction in the reconstructed aortic arch after Norwood. In this age group and setting, surgical arch augmentation is generally preferred over balloon angioplasty because of higher durability and lower restenosis risk in neo-aortic arch obstruction.\\nAlternative options: Balloon angioplasty (A) is sometimes used but has significant restenosis/reintervention rates in this lesion and is not typically considered the optimal definitive management when surgical repair is feasible. Fontan completion (C) is a later-stage palliation and does not address the arch stenosis. Heart transplant evaluation (D) is for end-stage systemic ventricular failure, which is not present. Afterload reduction (E) is palliative and does not relieve the fixed anatomical obstruction.\\nMain medical/logical issues: None substantial; item is consistent with pediatric cardiac surgery practice.\\nMinimal fix: Specify “symptomatic significant gradient across the neo-aortic arch” in the stem to further justify anatomic intervention over catheter-based palliation.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 2-year-old with hypoplastic left heart syndrome status post-Norwood; now has feeding intolerance and metabolic acidosis (low-output/systemic hypoperfusion signs), echo with preserved ventricular function but elevated right atrial pressure, and catheterization documenting stenosis at the neo-aortic arch. The clinical problem is symptomatic obstruction in the reconstructed aortic arch after Norwood. In this age group and setting, surgical arch augmentation is generally preferred over balloon angioplasty because of higher durability and lower restenosis risk in neo-aortic arch obstruction.\nAlternative options: Balloon angioplasty (A) is sometimes used but has significant restenosis/reintervention rates in this lesion and is not typically considered the optimal definitive management when surgical repair is feasible. Fontan completion (C) is a later-stage palliation and does not address the arch stenosis. Heart transplant evaluation (D) is for end-stage systemic ventricular failure, which is not present. Afterload reduction (E) is palliative and does not relieve the fixed anatomical obstruction.\nMain medical/logical issues: None substantial; item is consistent with pediatric cardiac surgery practice.\nMinimal fix: Specify “symptomatic significant gradient across the neo-aortic arch” in the stem to further justify anatomic intervention over catheter-based palliation.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-012", "question": "A 10-year-old girl with sickle cell disease presents with acute chest syndrome, fever, and hypoxia. Chest X-ray shows multilobar infiltrates. She is on hydroxyurea and has received pneumococcal vaccines. What is the most appropriate additional therapy to reduce morbidity?", "options": ["Exchange transfusion", "Intravenous ceftriaxone monotherapy", "High-dose corticosteroids", "Inhaled nitric oxide", "Therapeutic anticoagulation"], "answer": "A", "answer_index": 0, "explanation": "Exchange transfusion is indicated for severe acute chest syndrome in sickle cell disease to reduce sickle hemoglobin and improve oxygenation. Antibiotics address infection but not vaso-occlusion; steroids are controversial and risk rebound. Nitric oxide and anticoagulation lack evidence in this context.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 10-year-old with sickle cell disease, acute chest syndrome, fever, hypoxia, multilobar infiltrates. This represents severe acute chest syndrome with significant oxygenation impairment and extensive radiographic involvement, where exchange transfusion is recommended to rapidly lower HbS and improve oxygen delivery, reducing morbidity.\\nOption analysis: A (keyed) fits standard guidance for severe/lobar or progressive acute chest syndrome to reduce morbidity and progression to respiratory failure. B (ceftriaxone monotherapy) is inadequate for typical empiric coverage (usually a cephalosporin plus macrolide; also doesn’t address vaso-occlusion). C (high-dose corticosteroids) are controversial with risk of rebound pain/ACS and not routine standard of care. D (inhaled nitric oxide) has not shown clear benefit in sickle ACS. E (therapeutic anticoagulation) has no established role in primary management of ACS absent venous thromboembolism.\\nMain medical/logical issues: Stem could more explicitly state clinical severity (e.g., ICU-level hypoxia, increasing oxygen requirements), but multilobar infiltrates plus hypoxia are reasonably taken as severe. No major inaccuracies.\\nMinimal fix: Specify severity (e.g., “requiring high-flow oxygen with worsening respiratory distress”) to more clearly justify the need for exchange transfusion over simple transfusion or antibiotics alone.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 10-year-old with sickle cell disease, acute chest syndrome, fever, hypoxia, multilobar infiltrates. This represents severe acute chest syndrome with significant oxygenation impairment and extensive radiographic involvement, where exchange transfusion is recommended to rapidly lower HbS and improve oxygen delivery, reducing morbidity.\nOption analysis: A (keyed) fits standard guidance for severe/lobar or progressive acute chest syndrome to reduce morbidity and progression to respiratory failure. B (ceftriaxone monotherapy) is inadequate for typical empiric coverage (usually a cephalosporin plus macrolide; also doesn’t address vaso-occlusion). C (high-dose corticosteroids) are controversial with risk of rebound pain/ACS and not routine standard of care. D (inhaled nitric oxide) has not shown clear benefit in sickle ACS. E (therapeutic anticoagulation) has no established role in primary management of ACS absent venous thromboembolism.\nMain medical/logical issues: Stem could more explicitly state clinical severity (e.g., ICU-level hypoxia, increasing oxygen requirements), but multilobar infiltrates plus hypoxia are reasonably taken as severe. No major inaccuracies.\nMinimal fix: Specify severity (e.g., “requiring high-flow oxygen with worsening respiratory distress”) to more clearly justify the need for exchange transfusion over simple transfusion or antibiotics alone.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-013", "question": "A 5-year-old boy with ataxia-telangiectasia develops progressive dysphagia and recurrent aspiration pneumonia. Genetic testing confirms ATM mutation. Videofluoroscopic swallow study shows pharyngeal dysmotility. What is the most appropriate long-term management to prevent pulmonary complications?", "options": ["Gastrostomy tube placement for enteral feeding", "Speech therapy with thickened liquids", "Botulinum toxin injection into cricopharyngeus", "Esophageal dilation procedure", "Prokinetic agent administration"], "answer": "A", "answer_index": 0, "explanation": "In ataxia-telangiectasia with severe dysphagia, gastrostomy tube bypasses aspiration risk and ensures nutrition, as the neurologic deficit is progressive. Speech therapy may help mildly but not prevent recurrent pneumonia; botox or dilation address specific issues not present here. Prokinetics do not resolve dysmotility.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 5-year-old with ataxia-telangiectasia (progressive neurodegenerative disorder), confirmed ATM mutation, progressive dysphagia, recurrent aspiration pneumonia, videofluoroscopic study showing pharyngeal dysmotility. The question asks for the most appropriate long-term management to prevent pulmonary complications. In a child with progressive neurogenic pharyngeal dysfunction and established recurrent aspiration, the safest long-term strategy to prevent further pulmonary injury is to bypass the oropharyngeal phase with gastrostomy tube feeding. Speech therapy with thickened liquids (B) may be helpful in mild/moderate dysphagia but is inadequate once recurrent aspiration pneumonias occur in a progressive neurologic disease; thus it is not the best long-term preventive measure. Botulinum toxin to cricopharyngeus (C) and esophageal dilation (D) target structural/UES or luminal obstruction, which are not described. Prokinetic agents (E) are for esophageal/gastric motility, not isolated pharyngeal dyscoordination. The logic and pathophysiology are standard and consistent with pediatric and neuromuscular dysphagia management principles. Minimal fix: Specify “severe oropharyngeal dysphagia with frank aspiration on swallow study” to further justify need for gastrostomy over conservative measures.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 5-year-old with ataxia-telangiectasia (progressive neurodegenerative disorder), confirmed ATM mutation, progressive dysphagia, recurrent aspiration pneumonia, videofluoroscopic study showing pharyngeal dysmotility. The question asks for the most appropriate long-term management to prevent pulmonary complications. In a child with progressive neurogenic pharyngeal dysfunction and established recurrent aspiration, the safest long-term strategy to prevent further pulmonary injury is to bypass the oropharyngeal phase with gastrostomy tube feeding. Speech therapy with thickened liquids (B) may be helpful in mild/moderate dysphagia but is inadequate once recurrent aspiration pneumonias occur in a progressive neurologic disease; thus it is not the best long-term preventive measure. Botulinum toxin to cricopharyngeus (C) and esophageal dilation (D) target structural/UES or luminal obstruction, which are not described. Prokinetic agents (E) are for esophageal/gastric motility, not isolated pharyngeal dyscoordination. The logic and pathophysiology are standard and consistent with pediatric and neuromuscular dysphagia management principles. Minimal fix: Specify “severe oropharyngeal dysphagia with frank aspiration on swallow study” to further justify need for gastrostomy over conservative measures.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-014", "question": "A neonate with trisomy 21 presents with bilious vomiting and abdominal distension. X-ray shows double bubble sign. Echocardiography reveals an atrioventricular septal defect. What is the most appropriate preoperative management prior to duodenal atresia repair?", "options": ["Cardiac catheterization for defect assessment", "Prostaglandin infusion to maintain ductal patency", "Nasogastric decompression and parenteral nutrition", "Immediate surgical repair without delay", "Antibiotic prophylaxis for endocarditis"], "answer": "C", "answer_index": 2, "explanation": "Duodenal atresia in Down syndrome requires NG decompression and TPN to stabilize before surgery, allowing time for cardiac evaluation. Catheterization is invasive and not routine; PGE is for ductal-dependent lesions. Immediate repair risks instability; prophylaxis is perioperative.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Neonate with trisomy 21, bilious vomiting, abdominal distension, “double bubble” sign on X‑ray (classic duodenal atresia), and a known atrioventricular septal defect, being prepared for surgical repair of the atresia. Question asks for the most appropriate preoperative management.\\n\\nBest-answer reasoning: Standard preoperative care for duodenal atresia includes gastric decompression, fluid/electrolyte resuscitation, and provision of nutrition (often parenteral) while optimizing for surgery and assessing associated anomalies (notably cardiac defects in Down syndrome). Thus, nasogastric decompression and parenteral nutrition (C) is clearly appropriate.\\n\\nChoice critiques:\\nA: Routine pre-op cardiac evaluation is typically by echocardiography; cardiac catheterization is reserved for specific indications, not standard in a stable neonate.\\nB: Prostaglandin is used for ductal-dependent lesions; AVSD is not primarily ductal-dependent.\\nD: While repair should not be excessively delayed, some stabilization and evaluation are standard; “immediate” without stabilization is suboptimal.\\nE: Endocarditis prophylaxis is perioperative/ongoing, not the key preoperative management priority for duodenal atresia.\\n\\nMain medical issues: None significant; item aligns with accepted practice.\\n\\nMinimal fix: Specify that the infant is hemodynamically stable to support deferring immediate surgery for stabilization and TPN.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Neonate with trisomy 21, bilious vomiting, abdominal distension, “double bubble” sign on X‑ray (classic duodenal atresia), and a known atrioventricular septal defect, being prepared for surgical repair of the atresia. Question asks for the most appropriate preoperative management.\n\nBest-answer reasoning: Standard preoperative care for duodenal atresia includes gastric decompression, fluid/electrolyte resuscitation, and provision of nutrition (often parenteral) while optimizing for surgery and assessing associated anomalies (notably cardiac defects in Down syndrome). Thus, nasogastric decompression and parenteral nutrition (C) is clearly appropriate.\n\nChoice critiques:\nA: Routine pre-op cardiac evaluation is typically by echocardiography; cardiac catheterization is reserved for specific indications, not standard in a stable neonate.\nB: Prostaglandin is used for ductal-dependent lesions; AVSD is not primarily ductal-dependent.\nD: While repair should not be excessively delayed, some stabilization and evaluation are standard; “immediate” without stabilization is suboptimal.\nE: Endocarditis prophylaxis is perioperative/ongoing, not the key preoperative management priority for duodenal atresia.\n\nMain medical issues: None significant; item aligns with accepted practice.\n\nMinimal fix: Specify that the infant is hemodynamically stable to support deferring immediate surgery for stabilization and TPN.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-015", "question": "A 35-year-old woman at 20 weeks gestation with twin pregnancy develops acute shortness of breath and hemoptysis. Echocardiography shows severe mitral stenosis with pulmonary hypertension. She is hemodynamically stable. What is the most appropriate management?", "options": ["Percutaneous mitral balloon valvuloplasty", "Open mitral commissurotomy", "Therapeutic anticoagulation with heparin", "Beta-blocker therapy for rate control", "Termination of pregnancy"], "answer": "A", "answer_index": 0, "explanation": "Percutaneous valvuloplasty is preferred for severe mitral stenosis in pregnancy as it avoids cardiopulmonary bypass risks to the fetus. Open surgery is higher risk; anticoagulation prevents clots but not stenosis. Beta-blockers manage symptoms but do not address the valve. Termination is not indicated if treatable.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: 20 weeks gestation with twins, severe mitral stenosis, pulmonary hypertension, acute dyspnea and hemoptysis, but explicitly hemodynamically stable. Question asks “most appropriate management” (immediate next step vs definitive therapy not specified).\\nMain logical issues: For pregnant patients with severe symptomatic mitral stenosis, percutaneous balloon mitral valvotomy is appropriate when symptoms are severe (NYHA III–IV) or refractory to medical therapy. However, the stem only notes acute dyspnea/hemoptysis without detailing NYHA class, prior medical management, or echocardiographic suitability for valvotomy (valve morphology, absence of LA thrombus, severe MR). Hemodynamic stability is specifically stated, which can argue for initial medical therapy (e.g., beta-blocker and diuretics). Thus both A (definitive) and D (initial medical) are defensible depending on intended time frame, making the key to A rely on unstated assumptions.\\nMedical accuracy: The explanation about avoiding cardiopulmonary bypass and limitations of anticoagulation/beta-blockers is broadly correct, but it overstates that beta-blockers “do not address the valve” when they are standard first-line symptom control.\\nMinimal fix: Clarify that she is NYHA class III–IV with symptoms despite optimal medical therapy and valve morphology suitable for balloon valvotomy, or rephrase to “best definitive treatment during this pregnancy.”\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: 20 weeks gestation with twins, severe mitral stenosis, pulmonary hypertension, acute dyspnea and hemoptysis, but explicitly hemodynamically stable. Question asks “most appropriate management” (immediate next step vs definitive therapy not specified).\nMain logical issues: For pregnant patients with severe symptomatic mitral stenosis, percutaneous balloon mitral valvotomy is appropriate when symptoms are severe (NYHA III–IV) or refractory to medical therapy. However, the stem only notes acute dyspnea/hemoptysis without detailing NYHA class, prior medical management, or echocardiographic suitability for valvotomy (valve morphology, absence of LA thrombus, severe MR). Hemodynamic stability is specifically stated, which can argue for initial medical therapy (e.g., beta-blocker and diuretics). Thus both A (definitive) and D (initial medical) are defensible depending on intended time frame, making the key to A rely on unstated assumptions.\nMedical accuracy: The explanation about avoiding cardiopulmonary bypass and limitations of anticoagulation/beta-blockers is broadly correct, but it overstates that beta-blockers “do not address the valve” when they are standard first-line symptom control.\nMinimal fix: Clarify that she is NYHA class III–IV with symptoms despite optimal medical therapy and valve morphology suitable for balloon valvotomy, or rephrase to “best definitive treatment during this pregnancy.”", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-016", "question": "A 29-year-old woman with polycystic ovary syndrome undergoes in vitro fertilization and develops abdominal distension, dyspnea, and oliguria 5 days post-embryo transfer. Ultrasound shows massive ascites and enlarged ovaries. Laboratory tests reveal hemoconcentration and hyponatremia. What is the most appropriate initial management?", "options": ["Intravenous albumin infusion and paracentesis", "Diuretic therapy with furosemide", "Heparin prophylaxis alone", "Expectant management at home", "Surgical ovarian detorsion"], "answer": "A", "answer_index": 0, "explanation": "Severe ovarian hyperstimulation syndrome requires fluid management with albumin for oncotic pressure and paracentesis for symptomatic relief. Diuretics worsen hypovolemia; heparin prevents thrombosis but is adjunctive. Expectant management risks deterioration; detorsion is for torsion, not OHSS.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Young woman with PCOS undergoing IVF; onset 5 days after embryo transfer; abdominal distension, dyspnea, oliguria; ultrasound with massive ascites and enlarged ovaries; labs with hemoconcentration and hyponatremia. These are classic for severe ovarian hyperstimulation syndrome (OHSS) with third-spacing and intravascular depletion.\\n\\nIn severe OHSS, initial management focuses on careful volume resuscitation and maintaining oncotic pressure (e.g., IV albumin) plus therapeutic paracentesis for respiratory compromise/tense ascites. Thus option A is appropriate and comprehensive.\\n\\nOption B (furosemide) is inappropriate initially because diuretics can worsen intravascular hypovolemia in OHSS. C (heparin prophylaxis alone) addresses thrombosis risk but does not treat the primary hemodynamic problem and is not sufficient as initial management. D (expectant management at home) is unsafe in severe OHSS with dyspnea and oliguria. E (surgical ovarian detorsion) is for torsion, which is not suggested here.\\n\\nNo major logical gaps or internal contradictions. Item cleanly discriminates the intended teaching point and matches current standard management of severe OHSS.\\n\\nMinimal fix: Specify “hospital admission with” before option A to emphasize appropriate setting for this level of severity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Young woman with PCOS undergoing IVF; onset 5 days after embryo transfer; abdominal distension, dyspnea, oliguria; ultrasound with massive ascites and enlarged ovaries; labs with hemoconcentration and hyponatremia. These are classic for severe ovarian hyperstimulation syndrome (OHSS) with third-spacing and intravascular depletion.\n\nIn severe OHSS, initial management focuses on careful volume resuscitation and maintaining oncotic pressure (e.g., IV albumin) plus therapeutic paracentesis for respiratory compromise/tense ascites. Thus option A is appropriate and comprehensive.\n\nOption B (furosemide) is inappropriate initially because diuretics can worsen intravascular hypovolemia in OHSS. C (heparin prophylaxis alone) addresses thrombosis risk but does not treat the primary hemodynamic problem and is not sufficient as initial management. D (expectant management at home) is unsafe in severe OHSS with dyspnea and oliguria. E (surgical ovarian detorsion) is for torsion, which is not suggested here.\n\nNo major logical gaps or internal contradictions. Item cleanly discriminates the intended teaching point and matches current standard management of severe OHSS.\n\nMinimal fix: Specify “hospital admission with” before option A to emphasize appropriate setting for this level of severity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-017", "question": "A 42-year-old woman with a history of cervical cancer treated with radiation presents with postmenopausal bleeding. Endometrial biopsy shows atypical hyperplasia. MRI reveals myometrial invasion. What is the most appropriate management considering her radiation history?", "options": ["Hysterectomy with bilateral salpingo-oophorectomy", "High-dose progestin therapy", "Repeat radiation to the pelvis", "Chemotherapy with carboplatin and paclitaxel", "Endometrial ablation"], "answer": "A", "answer_index": 0, "explanation": "Invasive endometrial cancer post-pelvic radiation requires surgical staging via hysterectomy, as further radiation risks complications like fistula. Progestins are for non-invasive hyperplasia; repeat radiation is contraindicated. Chemotherapy is adjuvant, not primary; ablation is insufficient for cancer.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 42-year-old woman, prior pelvic radiation for cervical cancer, now postmenopausal bleeding; endometrial biopsy shows atypical hyperplasia, MRI reveals myometrial invasion (i.e., at least invasive endometrial carcinoma). The question asks for most appropriate management given prior radiation.\\n\\nMost likely diagnosis/mechanism: Invasive endometrial carcinoma in a previously irradiated pelvis. Standard management for surgically resectable disease is total hysterectomy with bilateral salpingo-oophorectomy and staging; repeat pelvic radiation carries high risk (e.g., fistula) and is generally avoided.\\n\\nEvaluation of options: A (TAH-BSO) is guideline-consistent primary therapy for invasive, operable endometrial cancer, and especially appropriate because additional pelvic radiation is relatively contraindicated after prior radiation. B (high-dose progestin) is reserved for complex atypical hyperplasia or very early, noninvasive cancer in patients who are poor surgical candidates or desire fertility; not appropriate for MRI-demonstrated myometrial invasion in a fit 42-year-old. C (repeat radiation) is unsafe after prior pelvic RT. D (carboplatin/paclitaxel) is typically adjuvant or for advanced/recurrent disease, not primary localized management. E (ablation) is contraindicated in suspected malignancy.\\n\\nMain medical/logical issues: None significant; terminology (“atypical hyperplasia” vs carcinoma) is mildly imprecise but MRI invasion justifies cancer-level treatment.\\n\\nMinimal fix: State biopsy shows endometrioid adenocarcinoma (rather than atypical hyperplasia) to align pathology with invasive disease on MRI.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 42-year-old woman, prior pelvic radiation for cervical cancer, now postmenopausal bleeding; endometrial biopsy shows atypical hyperplasia, MRI reveals myometrial invasion (i.e., at least invasive endometrial carcinoma). The question asks for most appropriate management given prior radiation.\n\nMost likely diagnosis/mechanism: Invasive endometrial carcinoma in a previously irradiated pelvis. Standard management for surgically resectable disease is total hysterectomy with bilateral salpingo-oophorectomy and staging; repeat pelvic radiation carries high risk (e.g., fistula) and is generally avoided.\n\nEvaluation of options: A (TAH-BSO) is guideline-consistent primary therapy for invasive, operable endometrial cancer, and especially appropriate because additional pelvic radiation is relatively contraindicated after prior radiation. B (high-dose progestin) is reserved for complex atypical hyperplasia or very early, noninvasive cancer in patients who are poor surgical candidates or desire fertility; not appropriate for MRI-demonstrated myometrial invasion in a fit 42-year-old. C (repeat radiation) is unsafe after prior pelvic RT. D (carboplatin/paclitaxel) is typically adjuvant or for advanced/recurrent disease, not primary localized management. E (ablation) is contraindicated in suspected malignancy.\n\nMain medical/logical issues: None significant; terminology (“atypical hyperplasia” vs carcinoma) is mildly imprecise but MRI invasion justifies cancer-level treatment.\n\nMinimal fix: State biopsy shows endometrioid adenocarcinoma (rather than atypical hyperplasia) to align pathology with invasive disease on MRI.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-018", "question": "A 65-year-old man with aortic stenosis undergoes transcatheter aortic valve replacement under monitored anesthesia care. Intraoperatively, he develops complete heart block. Temporary pacing is initiated, but rhythm does not recover. What is the most appropriate long-term management?", "options": ["Permanent pacemaker implantation", "Observation for 7 days with temporary pacing", "Amiodarone infusion for rhythm control", "Dual-chamber ICD placement", "Surgical valve revision"], "answer": "A", "answer_index": 0, "explanation": "Complete heart block post-TAVR often persists due to conduction system compression, necessitating permanent pacemaker. Observation may be trialed but evidence supports early implantation if persistent. Amiodarone is not for block; ICD is for ventricular arrhythmias. Revision is for valve issues.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 65-year-old man with aortic stenosis; undergoes TAVR under monitored anesthesia care; develops complete heart block intraoperatively; temporary pacing is initiated; rhythm does not recover (i.e., persistent complete heart block). The question asks for most appropriate long-term management.\\n\\nPersistent complete heart block following TAVR is a well-recognized complication due to mechanical injury/compression of the conduction system and typically warrants permanent pacemaker implantation once it is clear the block is not transient. Thus option A is the best answer.\\n\\nOption B (observation with temporary pacing) is less appropriate as “rhythm does not recover” indicates persistence during the procedure and the question asks about long-term management, not immediate post-op monitoring strategy. C (amiodarone) is inappropriate for AV block; D (ICD) addresses malignant ventricular arrhythmias, not isolated conduction block; E (surgical valve revision) is not standard for isolated post-TAVR AV block without structural valve issue.\\n\\nNo major medical inaccuracies are present; some centers may observe up to several days before implant, but the question clearly frames this as a settled, persistent block needing definitive therapy.\\n\\nMinimal fix: Clarify duration (e.g., “persists for >24–48 hours post-TAVR”) to strengthen justification for immediate pacemaker implantation.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 65-year-old man with aortic stenosis; undergoes TAVR under monitored anesthesia care; develops complete heart block intraoperatively; temporary pacing is initiated; rhythm does not recover (i.e., persistent complete heart block). The question asks for most appropriate long-term management.\n\nPersistent complete heart block following TAVR is a well-recognized complication due to mechanical injury/compression of the conduction system and typically warrants permanent pacemaker implantation once it is clear the block is not transient. Thus option A is the best answer.\n\nOption B (observation with temporary pacing) is less appropriate as “rhythm does not recover” indicates persistence during the procedure and the question asks about long-term management, not immediate post-op monitoring strategy. C (amiodarone) is inappropriate for AV block; D (ICD) addresses malignant ventricular arrhythmias, not isolated conduction block; E (surgical valve revision) is not standard for isolated post-TAVR AV block without structural valve issue.\n\nNo major medical inaccuracies are present; some centers may observe up to several days before implant, but the question clearly frames this as a settled, persistent block needing definitive therapy.\n\nMinimal fix: Clarify duration (e.g., “persists for >24–48 hours post-TAVR”) to strengthen justification for immediate pacemaker implantation.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-019", "question": "A 50-year-old woman with myasthenia gravis undergoes thymectomy. Postoperatively, she develops respiratory failure requiring reintubation. Acetylcholinesterase inhibitors are maximized. What is the most appropriate adjunctive therapy to facilitate extubation?", "options": ["Intravenous immunoglobulin", "Plasmapheresis", "High-dose corticosteroids", "Cyclosporine initiation", "Rituximab infusion"], "answer": "B", "answer_index": 1, "explanation": "Plasmapheresis rapidly removes autoantibodies in myasthenic crisis, aiding quicker recovery than IVIG, which is slower. Corticosteroids risk initial worsening; cyclosporine and rituximab are long-term therapies not suitable for acute crisis.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Known myasthenia gravis, recent thymectomy (perioperative trigger), postoperative respiratory failure requiring reintubation despite maximized acetylcholinesterase inhibitor therapy. This describes an acute myasthenic crisis needing rapid immunomodulation to allow ventilator weaning. Among options, plasmapheresis offers the fastest reduction of circulating AChR antibodies and is guideline-consistent for acute crisis, particularly in intubated patients.\\nEvaluation of alternatives: IVIG (A) is also used for myasthenic crisis but has a slower onset of effect; when a single best answer emphasizing most rapid adjunct is needed, plasmapheresis is preferred. High-dose corticosteroids (C) can transiently exacerbate weakness and are not first-line acute rescue in this context. Cyclosporine (D) and rituximab (E) are chronic immunosuppressive strategies with delayed onset and no role in immediate extubation planning.\\nMain logical issues: None; the stem clearly implies need for rapid adjunctive therapy. The teaching point (PLEX vs IVIG timing) is consistent with mainstream practice.\\nMinimal fix: Add a phrase such as “which therapy provides the most rapid clinical improvement?” to explicitly emphasize the timing rationale over IVIG.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Known myasthenia gravis, recent thymectomy (perioperative trigger), postoperative respiratory failure requiring reintubation despite maximized acetylcholinesterase inhibitor therapy. This describes an acute myasthenic crisis needing rapid immunomodulation to allow ventilator weaning. Among options, plasmapheresis offers the fastest reduction of circulating AChR antibodies and is guideline-consistent for acute crisis, particularly in intubated patients.\nEvaluation of alternatives: IVIG (A) is also used for myasthenic crisis but has a slower onset of effect; when a single best answer emphasizing most rapid adjunct is needed, plasmapheresis is preferred. High-dose corticosteroids (C) can transiently exacerbate weakness and are not first-line acute rescue in this context. Cyclosporine (D) and rituximab (E) are chronic immunosuppressive strategies with delayed onset and no role in immediate extubation planning.\nMain logical issues: None; the stem clearly implies need for rapid adjunctive therapy. The teaching point (PLEX vs IVIG timing) is consistent with mainstream practice.\nMinimal fix: Add a phrase such as “which therapy provides the most rapid clinical improvement?” to explicitly emphasize the timing rationale over IVIG.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-020", "question": "A 60-year-old woman with bipolar disorder on lithium therapy presents with tremors, confusion, and ataxia. Serum lithium level is 2.5 mmol/L. She has acute kidney injury. What is the most appropriate management to expedite lithium clearance?", "options": ["Hemodialysis", "Forced diuresis with saline", "Gastric lavage", "Activated charcoal administration", "Discontinuation and observation"], "answer": "A", "answer_index": 0, "explanation": "Hemodialysis is indicated for severe lithium toxicity with neurologic symptoms and renal impairment, as it efficiently clears lithium. Diuresis is ineffective with AKI; lavage and charcoal do not bind lithium. Observation risks prolonged toxicity.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 60-year-old on chronic lithium, now with neurologic toxicity (tremors, confusion, ataxia), serum lithium 2.5 mmol/L (markedly elevated), and acute kidney injury. The question asks for the most appropriate management to expedite lithium clearance.\\nHemodialysis is the standard of care for severe lithium toxicity, especially with neurologic findings and impaired renal function, because lithium is small, water-soluble, not protein-bound, and dialyzable. Diuresis with saline (B) is not reliable or appropriate in AKI and is specifically noted as ineffective. Gastric lavage (C) is only useful very early after acute ingestion and not for established chronic toxicity; also risk–benefit is poor. Activated charcoal (D) does not bind lithium and is ineffective. Discontinuation and observation (E) is inappropriate given severity and renal impairment.\\nThe item supports a clear single best answer that matches the key, with no internal contradictions and options that are appropriately discriminating.\\nMain medical accuracy issues: none; explanation correctly states dialysis indications and limitations of alternatives.\\nMinimal fix: Optionally specify this is chronic lithium therapy with current toxicity to reinforce dialysis indication, but item is already adequate and unambiguous.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 60-year-old on chronic lithium, now with neurologic toxicity (tremors, confusion, ataxia), serum lithium 2.5 mmol/L (markedly elevated), and acute kidney injury. The question asks for the most appropriate management to expedite lithium clearance.\nHemodialysis is the standard of care for severe lithium toxicity, especially with neurologic findings and impaired renal function, because lithium is small, water-soluble, not protein-bound, and dialyzable. Diuresis with saline (B) is not reliable or appropriate in AKI and is specifically noted as ineffective. Gastric lavage (C) is only useful very early after acute ingestion and not for established chronic toxicity; also risk–benefit is poor. Activated charcoal (D) does not bind lithium and is ineffective. Discontinuation and observation (E) is inappropriate given severity and renal impairment.\nThe item supports a clear single best answer that matches the key, with no internal contradictions and options that are appropriately discriminating.\nMain medical accuracy issues: none; explanation correctly states dialysis indications and limitations of alternatives.\nMinimal fix: Optionally specify this is chronic lithium therapy with current toxicity to reinforce dialysis indication, but item is already adequate and unambiguous.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]